<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00254852</url>
  </required_header>
  <id_info>
    <org_study_id>CR04-004</org_study_id>
    <nct_id>NCT00254852</nct_id>
  </id_info>
  <brief_title>Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft</brief_title>
  <official_title>A Single Blind, Multi-Center, Randomized, Prospective Clinical Study Comparing Optecure™ Autograft Extender to Autograft Only in Fusion of the Lumbar Spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Exactech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Exactech</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare Optecure™ as an autograft extender (treatment) to&#xD;
      autograft alone (control) in patients undergoing 1 or 2 level fusion of the lumbar spine(one&#xD;
      level is defined as two adjacent vertebrae), L2 and below.&#xD;
&#xD;
      The primary endpoint will be the assessment of fusion by evaluation of x-rays taken following&#xD;
      surgery at each visit. The x-ray evaluation will be conducted by a radiologist who is blinded&#xD;
      to the type of treatment each patient has received.&#xD;
&#xD;
      Subjects will be seen at 6 weeks, 3 months, 6 months, 12 months, and 24 months postoperative&#xD;
      (post-op). Questionnaires and x-rays will be completed at each visit and a computed&#xD;
      tomography (CT) scan will be taken at the 12 month visit(and used to aid in assessment of&#xD;
      bridging bone, where appropriate).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autograft (bone taken from one part of the body and placed in another site on the same&#xD;
      individual) has long been considered the gold standard for lumbar spine fusion procedures.&#xD;
      Unfortunately, there are complications involved with autograft harvest such as donor site&#xD;
      morbidity, increased operating time, and limited supply. Therefore, the use of allograft&#xD;
      (bone taken from one body and placed into another individual) as a graft extender has become&#xD;
      an acceptable practice, especially in fusions of more than one level where larger quantities&#xD;
      of graft material are needed.&#xD;
&#xD;
      In this study, comparisons will be made between patients who are randomized to having fusion&#xD;
      with an allograft material (Optecure, Exactech, Inc.) mixed with an autograft to those&#xD;
      patients who are randomized to having fusion with autograft alone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow enrollment&#xD;
  </why_stopped>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic evidence of fusion on x-rays taken at each post-op visit</measure>
    <time_frame>Immediate post-op, 6-week, 3-month, 6-month, 1-year, 2-year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI) completed at each visit</measure>
    <time_frame>pre-operative, 6-week, 3-month, 6-month, 1-year, 2-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-12 patient health surveys completed at each visit</measure>
    <time_frame>Pre-operative, 6-week, 3-month, 6-month, 1-year, 2-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived pain noted on visual analog scales (VAS) at each visit</measure>
    <time_frame>Pre-operative, 6-week, 3-month, 6-month, 1-year, 2-year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Stenosis</condition>
  <condition>Spondylolisthesis</condition>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This treatment arm includes autograft harvested from local bone and / or the iliac crest, supplemented with a demineralized bone matrix (DBM) autograft extender, Optecure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This treatment arm includes autograft harvested from local bone and / or the iliac crest.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior Lateral Fusion (PLF)</intervention_name>
    <description>Posterior lateral fusion (PLF) of the lumbar spine</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>O</arm_group_label>
    <other_name>PLF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anterior Lumbar Interbody Fusion (ALIF)</intervention_name>
    <description>Anterior lumbar interbody fusion (ALIF)</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>O</arm_group_label>
    <other_name>ALIF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transforaminal lumbar interbody fusion (TLIF)</intervention_name>
    <description>Transforaminal lumbar interbody fusion (TLIF)</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>O</arm_group_label>
    <other_name>TLIF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Posterior lumbar interbody fusion (PLIF)</intervention_name>
    <description>Posterior lumbar interbody fusion (PLIF)</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>O</arm_group_label>
    <other_name>PLIF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extreme lateral interbody fusion (XLIF)</intervention_name>
    <description>Extreme lateral interbody fusion (XLIF)</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>O</arm_group_label>
    <other_name>XLIF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is indicated for primary lumbar fusion of 1 or 2 segments, L2 to S1&#xD;
&#xD;
          -  Patient is willing to be blindly randomized to treatment or control and remain blinded&#xD;
             for 2 years of follow-up&#xD;
&#xD;
          -  Patient is at least twenty-one (21) years of age&#xD;
&#xD;
          -  Patient is expected to survive at least 2 years beyond surgery&#xD;
&#xD;
          -  Patient is willing to participate by complying with pre- and postoperative visit&#xD;
             requirements, including: completion of questionnaires, functional performance tests,&#xD;
             and radiographs/CT scan&#xD;
&#xD;
          -  Patient is willing and able to review and sign a study Informed Consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient has a mental or physical condition that would invalidate evaluation results&#xD;
&#xD;
          -  Patient is pregnant&#xD;
&#xD;
          -  Patient is a prisoner&#xD;
&#xD;
          -  Patient has a systemic infection or infection at the proposed surgical site&#xD;
&#xD;
          -  Patient has osteopenia, osteoporosis, or osteomalacia to a degree that spinal&#xD;
             instrumentation would be contraindicated&#xD;
&#xD;
          -  Patient has a disease of bone metabolism&#xD;
&#xD;
          -  Patient is undergoing chemotherapy or radiation treatment&#xD;
&#xD;
          -  Patient is currently involved in a study of another product for a similar purpose&#xD;
&#xD;
          -  Patient requires post-op management with nonsteroidal anti-inflammatory drugs (NSAIDs)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amir Fayyazi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VSAS Orthopedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Orthopaedic Surgical Group</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slocum Dickson Medical Group</name>
      <address>
        <city>New Hartford</city>
        <state>New York</state>
        <zip>13413</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State University of New York, Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NeuroSpine Solutions, P.C.</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>November 15, 2005</study_first_submitted>
  <study_first_submitted_qc>November 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2005</study_first_posted>
  <last_update_submitted>November 20, 2013</last_update_submitted>
  <last_update_submitted_qc>November 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary lumbar fusion</keyword>
  <keyword>Demineralized Bone Matrix</keyword>
  <keyword>DBM</keyword>
  <keyword>Optecure</keyword>
  <keyword>Allograft</keyword>
  <keyword>Autograft</keyword>
  <keyword>Lumbar fusion</keyword>
  <keyword>Interbody fusion</keyword>
  <keyword>Instrumented fusion</keyword>
  <keyword>Non-instrumented fusion</keyword>
  <keyword>Exactech</keyword>
  <keyword>Spinal fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

